Autres langues GlaxoSmithKline Pharmaceuticals Limited NSE India S.E.

Actions

GLAXO

INE159A01016

Produits pharmaceutiques

Marché Fermé - NSE India S.E. Autres places de cotation 13:05:07 16/06/2026			Varia. 5j.	Varia. 1 janv.
2 202,80 ^INR	+3,78%		+0,37%	-10,95%

29/05	GlaxoSmithKline Pharmaceuticals Limited annonce la démission du Dr Simrat Sohal de ses fonctions de Compliance Officer et de membre de la haute direction, effective au 5 août 2026	CI
13/05	GlaxoSmithKline Pharmaceuticals affiche un bénéfice net consolidé en hausse au quatrième trimestre fiscal	MT

Autres langues

29/05	GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Dr. Simrat Sohal from Compliance Officer and Ceases to Be the Senior Management Personnel, Effective August 5, 2026
13/05	GlaxoSmithKline Pharmaceuticals Clocks Higher Fiscal Q4 Consolidated Net Profit
13/05	GlaxoSmithKline Pharmaceuticals March-quarter consol profit 2.78 billion rupees
13/05	GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2026
13/05	GlaxoSmithKline Pharmaceuticals Limited announces Annual dividend, payable on July 30, 2026
21/04	Glaxosmithkline Pharmaceuticals Limited Announces Appointment of Vinay Subramanian as Commercial Head ? Oncology and Senior Management Personnel, Effective April 20, 2026
31/03	GlaxoSmithKline Pharmaceuticals receives TDS demand liability of 20.1 million rupees
24/03	GlaxoSmithKline Pharmaceuticals Ltd receives final order with tax demand liability of 232.1 mln rupees for AY 2023-24
16/03	GlaxoSmithKline Pharmaceuticals Ltd says Juby Chandy resigns as whole-time director and CFO
02/03	GlaxoSmithKline Pharmaceuticals Names CFO
02/03	GlaxoSmithKline Pharmaceuticals says Ronojit Biswas appointed as whole-time director & CFO
02/03	GlaxoSmithKline Pharmaceuticals Limited Announces Chief Financial Officer Changes
02/03	GlaxoSmithKline Pharmaceuticals Limited Announces Executive Changes
23/02	GlaxoSmithKline Pharmaceuticals gets order with total tax demand of 37.9 million rupees including tax, penalty
09/02	GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025
09/02	GlaxoSmithKline Pharmaceuticals Ltd Dec-quarter consol profit 2.96 billion rupees
31/12	GlaxoSmithKline Pharmaceuticals gets tax demand of 85.7 million rupees
22/12	GlaxoSmithKline Pharmaceuticals Ltd receives tax demand order of 9 million rupees
06/11	GlaxoSmithKline India reports higher second-quarter profit on specialty medicine growth
06/11	GlaxoSmithKline Pharma Q2 consol profit 2.57 billion rupees
29/10/25	GlaxoSmithKline Pharmaceuticals Limited Announces Resumption Of Sukanya Choudhury As Executive Vice President - Regulatory Affairs
08/09/25	Glaxosmithkline pharmaceuticals gets tax demand of total 18.1 million rupees
01/08/25	GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2025
09/07/25	Glaxosmithkline Pharmaceuticals Limited Appoints Vishwanath Swarup as Commercial Head - General Medicines, Effective July 9, 2025
27/06/25	Glaxosmithkline Pharmaceuticals Limited Approves Final Dividend for the Financial Year Ended March 31, 2025